FOLLOW THESE TIPS & TRAVEL A LITTLE EASIER - Start planning and preparing well
Let’s face it: when you have difficulty breathing, the thought of traveling far from home can feel like an ordeal, and sometimes even scary.
View articles and breathing tips, and learn how to connect with others like you.
View articles and breathing tips, and learn how to connect with others like you.
Let’s face it: when you have difficulty breathing, the thought of traveling far from home can feel like an ordeal, and sometimes even scary.
This link will take you to a site maintained by another party that is solely responsible for its contents.
AstraZeneca provides this link as a service to Web site visitors. AstraZeneca is not responsible for the Privacy Policy of any third party Web sites. We encourage you to read the privacy policy of every Web site you visit.
This link will take you to another web site. AstraZeneca provides this link as a service to site visitors. AstraZeneca is not responsible for the privacy policies of third party websites. We encourage you to read the policy of each website you visit.
Do you wish to continue?
X
As COVID-19 continues to impact the US, AstraZeneca remains committed to patient care. If there was ever a time to prioritize your health, it’s now. We are committed to doing everything we can to ensure our medicines remain available to you.
APPROVED USES
COPD: SYMBICORT 160/4.5 mcg is used long-term to improve symptoms of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, for better breathing and fewer flare-ups.
Asthma: SYMBICORT is for the treatment of asthma in patients 6 years and older whose asthma is not well‐controlled with an asthma-control medicine such as an inhaled corticosteroid (ICS) or whose asthma warrants treatment with both an ICS and a long-acting beta2-adrenergic agonist (LABA).
SYMBICORT is not used to relieve sudden breathing problems and will not replace a rescue inhaler.
You may report side effects related to AstraZeneca products by clicking here.
APPROVED USES
COPD: SYMBICORT 160/4.5 mcg is used long-term to improve symptoms of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, for better breathing and fewer flare-ups.
Asthma: SYMBICORT is for the treatment of asthma in patients 6 years and older whose asthma is not well‐controlled with an asthma-control medicine such as an inhaled corticosteroid (ICS) or whose asthma warrants treatment with both an ICS and a long-acting beta2-adrenergic agonist (LABA).
SYMBICORT is not used to relieve sudden breathing problems and will not replace a rescue inhaler.
You may report side effects related to AstraZeneca products by clicking here.